Alcon's Swiss Shares Slide After Sales Growth Disappoints

Dow Jones
11/11
 
 

Alcon shares in Switzerland dropped after the eyecare company reported third-quarter revenue growth that fell short of analysts' expectations and narrowed its full-year earnings outlook to the lower end of previous guidance.

Zurich-listed shares in Alcon were down 7.7% in European morning trading, taking the stock's year-to-date loss to 9.7%.

The company reported third-quarter net sales of $2.72 billion, up 5% compared with the year-earlier period when excluding currency changes.

Analysts polled by Visible Alpha had forecast Alcon's sales at $2.73 billion and constant-currency growth at 5.8%.

Alcon reported a 4% revenue increase in its surgical segment, with growing consumables and equipment sales offsetting a decline in implantables, and a 6% rise in its vision-care segment driven by both ocular-health products and contact lenses.

Net profit rose to $260 million from $237 million.

The company tightened its full-year guidance for both sales growth and core earnings. It now expects sales to grow 6% at constant currency, at the midpoint of its prior 5% to 7% range.

Core earnings per share are forecast to grow by 12% to 14%, which compares with Alcon's previous expectations of between 12% and 15%.

The weaker-than-expected sales and narrowed guidance won't be taken well by investors, as they reduce the prospect of positive surprises, analysts at RBC Capital Markets wrote in a note to clients.

Analysts at Swiss bank Vontobel said in a note that implantables sales missed expectations due to competitive pressures in the U.S., which would disappoint the market.

 
 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10